Literature DB >> 98959

Insulin antibodies in the serum of diabetic children treated from the diagnosis of the disease with highly purified insulins.

H K Akerblom, A L Mäkelä.   

Abstract

Fifty-one diabetic children, treated with highly purified, porcine insulins from the diagnosis of the disease were studied for the development of insulin antibodies during the first years of treatment. Sera were obtained before the start of treatment and at repeated intervals thereafter. Serum insulin antibodies were measured by three methods in three laboratories. Twenty-nine children were treated with R.I. (rare immunogenic) insulins at one department and 22 with MC (monocomponent) insulins at the other department. Before the start of treatment, serum insulin antibodies were almost invariably zero or below the limit of detection. During the first year a considerable number of cases, more than that reported for adults, formed detectable amounts of antibodies, and more so in the R.I. than in the MC series. The levels were however definitely lower than those observed with the same methods in diabetic children on conventional insulins. Analysis of variance showed no differences between the various age groups. No significant correlation was found between the highest titre of serum insulin antibodies on the one hand and insulin dose or glucosuria on the other hand. The results confirm the concept that children form antibodies to insulin more actively than adults.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 98959     DOI: 10.1111/j.1651-2227.1977.tb15124.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  6 in total

1.  Comparison of human and porcine insulin therapies in children with newly diagnosed diabetes mellitus.

Authors:  K Zuppinger; C Aebi; S Fankhauser; G Herz; R P Zurbrügg; K Schopfer; T M Neri
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

2.  Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission.

Authors:  J Ludvigsson
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

3.  Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production.

Authors:  N P Mann; D I Johnston; W G Reeves; M A Murphy
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

4.  Insulin autoantibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes--a poor predictor of clinical course and antibody response to exogenous insulin.

Authors:  J Karjalainen; M Knip; A Mustonen; H K Akerblom
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

5.  Abnormal proinsulin/C-peptide ratio in juvenile diabetes.

Authors:  J Ludvigsson; L Heding
Journal:  Acta Diabetol Lat       Date:  1982 Oct-Dec

6.  The immunogenic properties of a highly purified insulin preparation.

Authors:  N T Manning; M I Drury
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.